Status:

UNKNOWN

A Registry to Evaluate the Direct Flow Medical Transcatheter Aortic Valve System

Lead Sponsor:

Direct Flow Medical, Inc.

Conditions:

Aortic Valve Stenosis

Eligibility:

All Genders

71+ years

Brief Summary

The purpose of this postmarket Registry is to assess the standard of care and clinical outcomes of the Direct Flow Medical Transcatheter Aortic Valve System used in clinical routine according to the a...

Detailed Description

The patient population will include patients who are candidates for transcatheter aortic valve replacement (TAVR). According to routine practice, the heart team (interventional cardiologist and cardio...

Eligibility Criteria

Inclusion

  • Candidates for this study must meet all of the Indications criteria and none of the Contraindications.
  • Inclusion Criteria (Indications):
  • Age \> 70 years old
  • Severe aortic valve stenosis determined by echocardiogram and Doppler:
  • mean gradient \>40 mmHg or peak jet velocity \>4.0 m/s
  • aortic valve area ≤0.8 cm2 or aortic valve area index ≤0.5 cm2/m2
  • Symptomatic aortic valve stenosis (angina, congestive heart failure, NYHA Functional Class ≥ II, or syncope).
  • Patient is an extreme risk candidate for open surgical aortic valve repair such that the site Investigators (interventional cardiologist and cardiothoracic surgeon) agree that medical factors preclude operation, based on the conclusion that the probability of death or serious morbidity exceeds the probability of meaningful improvement due to the patient's co-morbidities (such as, but not limited to, severe COPD, porcelain aorta, previous thorax irradiation) or logistic EuroSCORE ≥ 20.
  • Exclusion Criteria (Contraindications):
  • The Direct Flow Medical device is contraindicated for post implant balloon valvuloplasty.

Exclusion

    Key Trial Info

    Start Date :

    March 1 2013

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2019

    Estimated Enrollment :

    1000 Patients enrolled

    Trial Details

    Trial ID

    NCT01845285

    Start Date

    March 1 2013

    End Date

    December 1 2019

    Last Update

    February 24 2016

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Elisabeth Krankenhaus

    Essen, Germany, 45138

    2

    Ospedale Niguarda Ca' Granda

    Milan, Italy, 20162